Brain biobank for research on brain diseases
Official title: University of Central Florida CereBank
Run by University of Central Florida · NCT06876857 · Data updated 2026-11-12
This study is setting up a brain bank to collect donated brains after death to help researchers find better ways to diagnose and treat brain diseases like Alzheimer's and dementia.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 50000 (estimated) |
| Sponsor | University of Central Florida Academic / other |
| Locations | 1 site (Orlando, Florida) |
| Status | Recruiting |
| Started | February 25, 2025 |
| Main results expected | February 25, 2075 |
| Study ends | February 25, 2075 |
| Registry record updated | March 14, 2025 |
| Trial ID | NCT06876857 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 18 and older who are willing to donate their brains for research purposes.
✕Probably not a fit
Patients who are minors, prisoners, or pregnant women will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The University of Central Florida CereBank aims to establish a brain biobank to support research focused on improving the diagnosis and treatment of brain diseases, including Alzheimer's disease and other forms of dementia. This observational study will collect biospecimens from individuals who donate their brains after death, which will then be utilized for various research and educational purposes. The initiative addresses the lack of a dedicated brain biobank in Central Florida, facilitating critical research efforts by the university's faculty.
Why it matters
Potential benefit: If successful, this biobank could significantly enhance the understanding and treatment of brain diseases, ultimately improving patient outcomes.
How similar studies have gone: Other brain biobanks have shown success in supporting research and advancing knowledge in the field, indicating that this approach is both viable and beneficial.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Be 18 years or older. * Able to provide informed consent. Persons who are unable to provide an informed consent will need a Legally Authorized Representative (LAR) to sign the informed consent. Exclusion Criteria: * minors (under age 18). * prisoners. * pregnant women.
Where it's running
-
University of Central Florida
Orlando, Florida, United States Recruiting
Study contacts
- Study coordinator: Britney-Ann Wray, BS, CTBS, CCRP
- Email: britney-ann.wray@ucf.edu
- Phone: 14072668742
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Exploration of whole-brain radiotherapy with PD-1 inhibitors for brain injury in SCLC
This study tests whether adding PD-1 inhibitors to chemotherapy and prophylactic brain irradiation helps some small cell lung cancer patients protect the brain.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Can a bedside brain scan (fNIRS) detect activity in healthy people and in people with disorders of consciousness
This observational study tests whether functional near-infrared spectroscopy (fNIRS) can measure brain activity at the bedside in healthy adults and in patients with disorders of consciousness in the Neuro-ICU.
-
Selective activation of the adrenomedullin receptor to provoke migraine in adults with migraine without aura
This study tests whether selectively activating the adrenomedullin receptor can trigger migraine attacks in adults who have migraine without aura, after blocking CGRP receptors.
-
Rapamycin-coated vertebral stents for symptomatic intracranial arterial narrowing
This trial will test whether rapamycin-coated stents placed in narrowed brain arteries can reduce the risk of stroke or death in adults whose symptoms have not improved with medicine.
-
The Coma Family Program: a resilience program for caregivers of patients with severe brain injury
This program tests whether the Coma Family Program can better reduce emotional distress in caregivers of patients with severe acute brain injury compared to a health education control.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.